Skip to main content
Quest Diagnostics

Harmonization of Real-World Data for Vaccine-Preventable Infectious Diseases: Integration of SARS-CoV-2 Diagnostic and Serologic Data From Multiple Sources

Harmonization of Real-World Data for Vaccine-Preventable Infectious Diseases: Integration of SARS-CoV-2 Diagnostic and Serologic Data From Multiple Sources

Authors: Ziemba YC, Yoon S, Kaufman HW, Meyer WA 3rd, Gillim L, Okoye N, Schleicher CB, Islam S, Sison CP, Pinto LA, Penberthy L, Crawford JM

Citation: Open Forum Infect Dis. 2026 Jul 23;13(8):ofag454. doi: 10.1093/ofid/ofag454

Specialties: Infectious disease

Related content

Publication
Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions
Publication
Evolution of Specimen Self-Collection in the COVID-19 Era: Implications for Population Health Management of Infectious Disease
Publication
Microfluidic immuno-serolomic assay reveals systems level association with COVID-19 pathology and vaccine protection
Publication
Real-World Lyme Disease Testing Results Using Modified vs Standard Two-Tier Test Protocols

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.